Low plasma adiponectin concentration is associated with myocardial infarction in young individuals

被引:53
作者
Persson, J. [1 ,5 ]
Lindberg, K. [2 ]
Gustafsson, T. P. [3 ]
Eriksson, P. [4 ]
Paulsson-Berne, G. [5 ]
Lundman, P. [1 ]
机构
[1] Danderyd Hosp, Karolinska Inst, Dept Clin Sci, Div Cardiovasc Med, Stockholm, Sweden
[2] Karolinska Inst, Novum, Dept Biosci & Nutr, S-10401 Stockholm, Sweden
[3] Karolinska Univ Hosp, Karolinska Inst, Dept Clin Chem, Stockholm, Sweden
[4] Karolinska Univ Hosp Solna, Karolinska Inst, Dept Med, Ctr Mol Med,Atherosclerosis Res Unit, Stockholm, Sweden
[5] Karolinska Univ Hosp Solna, Karolinska Inst, Dept Med, Ctr Mol Med,Cardiovasc Unit, Stockholm, Sweden
基金
瑞典研究理事会;
关键词
adiponectin; coronary heart disease; gene polymorphisms; genetics; CORONARY-ARTERY-DISEASE; ADIPOSE-SPECIFIC PROTEIN; INTIMA MEDIA THICKNESS; SERUM ADIPONECTIN; HEART-DISEASE; CARDIOVASCULAR-DISEASE; INSULIN-RESISTANCE; METABOLIC SYNDROME; NITRIC-OXIDE; FOLLOW-UP;
D O I
10.1111/j.1365-2796.2010.02247.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Persson J, Lindberg K, Gustafsson TP, Eriksson P, Paulsson-Berne G, Lundman P. (Danderyd University Hospital; Karolinska Institutet, Novum; Karolinska University Hospital, Karolinska Institutet; Atherosclerosis Research Unit; Karolinska Institutet, Stockholm, Sweden). Low plasma adiponectin concentration is associated with myocardial infarction in young individuals. J Intern Med 2010; 268: 194-205. Objective. The importance of adiponectin in coronary heart disease remains to be elucidated. Therefore, the associations between plasma adiponectin levels and i) myocardial infarction and ii) genetic variation within the adiponectin gene were investigated. Methods. The study included young survivors (age < 60 years) of a first myocardial infarction and gender- and age-matched controls (244 pairs). Adiponectin concentrations were analysed by radioimmunoassay. Two polymorphisms, rs266729 and rs1501299, of the adiponectin gene ADIPOQ were genotyped. Results. Adiponectin levels were inversely associated with myocardial infarction [odds ratio (OR) 9.3, 95% confidence interval (CI) 4.7-18.2, for the lowest quartile compared to the highest quartile]. This persisted after adjustment for history of hypertension, HDL cholesterol, smoking and body mass index (BMI) (OR 3.1, 95% CI 1.3-7.6). The rs266729 polymorphism was associated with adiponectin levels. Plasma adiponectin concentrations were lower in individuals with the rare G/G genotype [median 4.3 mg mL-1, interquartile range (IQR) 2.8-6.2] compared to the C/G (median 5.8 mg mL-1, IQR 3.9-8.0; P = 0.035) and C/C genotypes (median 5.5 mg mL-1, IQR 4.0-7.5; P = 0.083). Conclusion. Low plasma adiponectin concentrations are associated with myocardial infarction in individuals below the age of 60, and this remains significant after adjustment for history of hypertension, HDL cholesterol, smoking and BMI. In addition, adiponectin levels differ according to rs266729 genotype.
引用
收藏
页码:194 / 205
页数:12
相关论文
共 56 条
[41]   Adiponectin and mortality in patients undergoing coronary angiography [J].
Pilz, Stefan ;
Mangge, Harald ;
Wellnitz, Britta ;
Seelhorst, Ursula ;
Winkelmann, Bernhard R. ;
Tiran, Beate ;
Boehm, Bernhard O. ;
Maerz, Winfried .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (11) :4277-4286
[42]   Plasma adiponectin levels and risk of myocardial infarction in men [J].
Pischon, T ;
Girman, CJ ;
Hotamisligil, GS ;
Rifai, N ;
Hu, FB ;
Rimm, EB .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (14) :1730-1737
[43]   Adiponectin genetic variability, plasma adiponectin, and cardiovascular risk in patients with type 2 diabetes [J].
Qi, L ;
Doria, A ;
Manson, JE ;
Meigs, JB ;
Hunter, D ;
Mantzoros, CS ;
Hu, FB .
DIABETES, 2006, 55 (05) :1512-1516
[44]   The+276 polymorphism of the APM1 gene, plasma adiponectin concentration, and cardiovascular risk in diabetic men [J].
Qi, L ;
Li, T ;
Rimm, E ;
Zhang, CL ;
Rifai, N ;
Hunter, D ;
Doria, A ;
Hu, FB .
DIABETES, 2005, 54 (05) :1607-1610
[45]   Serum matrix metalloproteinase-3 concentration is influenced by MMP-3-1612 5A/6A promoter genotype and associated with myocardial infarction [J].
Samnegård, A ;
Silveira, A ;
Lundman, P ;
Boquist, S ;
Odeberg, J ;
Hulthe, J ;
Mcpheat, W ;
Tornvall, P ;
Bergstrand, L ;
Ericsson, CG ;
Hamsten, A ;
Eriksson, P .
JOURNAL OF INTERNAL MEDICINE, 2005, 258 (05) :411-419
[46]   Adiponectin and coronary heart disease: A prospective study and meta-analysis [J].
Sattar, Naveed ;
Wannamethee, Goya ;
Sarwar, Nadeem ;
Tchernova, Julia ;
Cherry, Lynne ;
Wallace, A. Michael ;
Danesh, John ;
Whincup, Peter H. .
CIRCULATION, 2006, 114 (07) :623-629
[47]   Adiponectin and protection against type 2 diabetes mellitus [J].
Spranger, J ;
Kroke, A ;
Möhlig, M ;
Bergmann, MM ;
Ristow, M ;
Boeing, H ;
Pfeiffer, AFH .
LANCET, 2003, 361 (9353) :226-228
[48]   Adiponectin and myocardial infarction: a paradox or a paradigm? [J].
Teoh, Hwee ;
Strauss, Martin H. ;
Szmitko, Paul E. ;
Verma, Subodh .
EUROPEAN HEART JOURNAL, 2006, 27 (19) :2266-2268
[49]   Adiponectin - journey from an adipocyte secretory protein to biomarker of the metabolic syndrome [J].
Trujillo, ME ;
Scherer, PE .
JOURNAL OF INTERNAL MEDICINE, 2005, 257 (02) :167-175
[50]   Estimation of contribution of changes in coronary care to improving survival, event rates, and coronary heart disease mortality across the WHO MONICA Project populations [J].
Tunstall-Pedoe, H ;
Vanuzzo, D ;
Hobbs, M ;
Mähönen, M ;
Cepaitis, Z ;
Kuulasmaa, K ;
Keil, U .
LANCET, 2000, 355 (9205) :688-700